
Trials explained
A peptide raised the share reaching a cell collection target to 92.5 percent
In 122 adults with a bone marrow cancer preparing for a transplant of their own stem cells, adding the peptide to the standard injection raised the share who collected enough cells in two sessions from 26.2 percent to 92.5 percent. A later comparison against the drug already in use found no advantage.
Latest briefings

Advanced Biologics
A self injected peptide beat placebo on a daily tasks score in 174 adults
In a 12 week randomised trial in a disease that weakens muscles, the peptide group improved 2.09 points more than the placebo group on an eight item scale of everyday tasks.
9 September 2026 · 6 min read · 4 sources

Advanced Biologics
An antibody carrying chemotherapy added five months in a 468 person trial
In advanced breast cancer of one type, median survival was 12.1 months against 6.7 months on the chemotherapy a doctor would otherwise have picked.
9 September 2026 · 6 min read · 3 sources

Trials explained
An antiviral shortened recovery in one trial and did not cut deaths in another
A blinded trial of 1,062 hospital patients found people recovered a median of five days sooner.
9 September 2026 · 6 min read · 4 sources

Advanced Biologics
No new HIV infections among 2,134 given a twice yearly injection
Two late stage randomised trials tested an injection given under the skin every 26 weeks against daily tablets.
9 September 2026 · 6 min read · 3 sources

Advanced Biologics
A swallowed peptide cut one kind of cholesterol 57.1 percent in a trial
The chain was joined into a ring so it could survive the gut, and 2,909 adults took it or an inactive tablet daily for 52 weeks.
8 September 2026 · 5 min read · 4 sources

Metabolic
A weight loss pill cut average body weight 11.2 percent in a 72 week trial
The tablet is put together by ordinary chemistry instead of being built as a peptide chain, and two late stage trials tested it against an inactive tablet in 3,127 and 1,613 adults.
8 September 2026 · 5 min read · 4 sources

Trials explained
A review of 19 skin trials found only a small effect on wrinkles
The 19 randomised trials covered 1,341 adults, and the pooled wrinkle figure only just cleared the usual threshold.
8 September 2026 · 6 min read · 4 sources

Advanced Biologics
A review found 20 studies of a copper peptide, only two of them in people
The review searched three databases through March 2026.
8 September 2026 · 6 min read · 5 sources

Trials explained
A higher amount barely changed the weight result in a 76 week trial
A late stage trial split 725 adults between a lower weekly injection, a higher one, and an inactive one.
8 September 2026 · 5 min read · 4 sources

Longevity
A weight loss drug group scored younger on body age tests in a trial
Blood stored during a 32 week trial in 84 adults was run through three tools that estimate biological age.
7 September 2026 · 5 min read · 4 sources

Trials explained
The biggest results for a three receptor drug are still unpublished
One mid stage trial has been through peer review, reporting an average weight reduction of 24.2 percent over 48 weeks.
7 September 2026 · 5 min read · 7 sources

Metabolic
Less thyroid eye disease on a newer blood sugar medicine, records show
Two matched groups of 173,618 patients with thyroid disease were followed through hospital records.
7 September 2026 · 6 min read · 7 sources
From the reference
Browse all 74 entries74
56
0
Newsletter
The MetaResearch briefing
A short email when a study worth reading is published, with the finding, its limits and the link to the source.




